Soliqua 100/33 (insulin glargine and lixisenatide)
100 U/mL / 33 ug/mL · Injection Solution
By Sanofi-Aventis U.S. LLC
- NDC
- 0024-5761
- Route
- Subcutaneous
- Therapeutic class
- GLP-1 Receptor Agonist , Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog , Insulin [CS]
- Marketing category
- BLA
Package sizes
- 1 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGENDC 0024-5761-01Available to order
- 5 SYRINGE in 1 CARTON (0024-5761-05) / 3 mL in 1 SYRINGE (0024-5761-02)NDC 0024-5761-05Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Diabetes & Endocrine
See all →
OMEOSPORT
Pellet
Guna spa
Available to source
GUNA-GERIATRICS
Solution / Drops
Guna spa
Available to source
PROCORT (1.85% hydrocortisone acetate - 1.15% pramoxine hci cream)
18.5 mg/g / 11.5 mg/g · Cream
Womens Choice Pharmaceuticals LLC
Available to source
Equate Hydrocortione (1% Hydrocortisone)
10 mg/g · Cream
Walmart Inc.
Available to source